News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Osprey Pharmaceuticals USA Raises $11 Million


9/3/2008 7:16:44 AM

Osprey Pharmaceuticals USA, a San Francisco-based developer of protein therapeutics for treating inflammatory diseases, has raised $11 million in first-round funding. Burrill & Co. led the round, and was joined by Novo Nordisk Biotech Fund, Yasuda Enterprise Development, GeneChem Therapeutics Venture Fund, BDC Venture Capital, Inc. and Western Technology Seed Investment Fund.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES